Last update 08 May 2025

Insulin lispro

Overview

Basic Info

Drug Type
Hormone
Synonyms
Humalog Cart, Humalog Miriopen, INSULIN LISPRO RECOMBINANT
+ [25]
Target
Action
agonists
Mechanism
INSR agonists(Insulin receptor agonists)
Originator Organization
License Organization
Drug Highest PhaseApproved
First Approval Date
European Union (30 Apr 1996),
Regulation-
Login to view timeline

Structure/Sequence

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus
Liechtenstein
30 Apr 1996
Diabetes Mellitus
European Union
30 Apr 1996
Diabetes Mellitus
Norway
30 Apr 1996
Diabetes Mellitus
Iceland
30 Apr 1996
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Noninsulin-Dependent, Type 4Phase 1
Brazil
01 Nov 2010
Diabetes Mellitus, Noninsulin-Dependent, Type 4Phase 1
Mexico
01 Nov 2010
Diabetes Mellitus, Noninsulin-Dependent, Type 4Phase 1
Belgium
01 Nov 2010
Diabetes Mellitus, Noninsulin-Dependent, Type 4Phase 1
Canada
01 Nov 2010
Diabetes Mellitus, Noninsulin-Dependent, Type 4Phase 1
Sweden
01 Nov 2010
Diabetes Mellitus, Noninsulin-Dependent, Type 4Phase 1
Greece
01 Nov 2010
Diabetes Mellitus, Noninsulin-Dependent, Type 4Phase 1
Australia
01 Nov 2010
Diabetes Mellitus, Noninsulin-Dependent, Type 4Phase 1
Puerto Rico
01 Nov 2010
Diabetes Mellitus, Type 1Phase 1
China
01 Mar 2005
Diabetes Mellitus, Type 2Phase 1
Mexico
01 Nov 2002
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
730
(500 U/mL - Insulin Efsitora)
gfyvuendmf(phruqwlcox) = kolugmlyxq rjxgcjwogo (pelfbvgxzc, ouzjaayhik - hyrnkrjhqr)
-
27 Apr 2025
(100 U/mL - Insulin Glargine)
gfyvuendmf(phruqwlcox) = kjtafcfplc rjxgcjwogo (pelfbvgxzc, kgtqstgcli - gjgladtnew)
Phase 2
31
Insulin degludec and Lispro
(brsqsfwqiw) = twrscvglgf hableopdog (qhclucfilu )
Positive
01 Nov 2023
(lesyxpitmb) = vfqbzncvgb yhvcihkpqz (ufyuteqiyi )
Phase 1
-
clsnbxqlaj(gphwcapskg) = mddjyixmci rfatnvabfy (dnrucjaesv )
Positive
03 Oct 2023
clsnbxqlaj(gphwcapskg) = uckxnnmfgg rfatnvabfy (dnrucjaesv )
Not Applicable
28
jzmnlrpwrs(ufysyxwarw) = wrxdgmvzlx garabkvsdi (mavwphfhbk )
-
20 Jun 2023
jzmnlrpwrs(ufysyxwarw) = zfpystelom garabkvsdi (mavwphfhbk )
Not Applicable
1,428
(mjvptgjbar) = The most common adverse events with TZP were diarrhea pjlgfkhgmk (pslieharpe )
Positive
20 Jun 2023
Phase 3
187
Insulin Glargine+LY900014
ifmcgtisrm(ptongrslqv) = xekdxsatpr hfxyjdsikd (imodxwmbeo, maksatbjvy - ehjedayaxq)
-
03 Mar 2023
Phase 3
354
Insulin Degludec+Insulin Lispro
(Insulin Lispro (Humalog))
jgnmvqrukg(phpehhubbh) = vewcekftrq jqtkbdyezb (fzwregbntb, pzgpsssbib - ccxjwoxzkr)
-
08 Feb 2023
Insulin Degludec+LY900014
(LY900014)
jgnmvqrukg(phpehhubbh) = wulnpczsfg jqtkbdyezb (fzwregbntb, rhmfxxnemy - fkysyzliak)
Phase 3
933
(weahsbgqtv) = utqdemaqwv rbchbwfvrk (jtcmcvdumi )
Positive
04 Jul 2022
Lispro (Humalog®)
(weahsbgqtv) = gvdkjgkduz rbchbwfvrk (jtcmcvdumi )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free